查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401929

2030 年药物医嘱遵从性市场预测：按类型、药物和地区分類的全球分析

Medication Adherence Market Forecasts to 2030 - Global Analysis By Type (Software Centric, Hardware Centric and Other Types), Medication and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球药物医嘱遵从性市场规模为 44.031 亿美元，预计到 2030 年将达到 136.153 亿美元，复合年增长率为 17.5。

治疗成功的一个重要部分是药物医嘱遵从性，或患者遵守建议处方方案的程度。市面上有许多旨在改善和追踪患者用药医嘱遵从性的技术、治疗方法和服务。该领域的创新包括可穿戴技术、智慧药丸分配器、行动健康应用程式和患者教育计划，以改善医疗保健提供者和患者之间的沟通，并最终确保患者遵守建议的用药常规。

根据CMS.gov 2022年12月更新数据，2021年全国医疗保健支出将成长2.7%，达到4.3兆美元，即人均12,914美元，占美国国内生产总值（GDP）的18.3%。

监理倡议

全球医疗产业的政府和监管机构越来越认识到，不遵守药物治疗会对医疗保健结果和支出产生重大影响。为此，颁布了许多法律和指南来促进药物医嘱遵从性计画的使用。此外，鼓励使用技术主导的药物医嘱遵从性工具的指南、对使用药物医嘱遵从性技术的医疗保健专业人员的付款奖励以及将药物医嘱遵从性测量纳入品质报告指标只是这些努力的几个例子。支持性法律规范促进尖端医嘱遵从性服务和技术的创建和应用。

缺乏标准化

缺乏标准化协议和资料格式阻碍了技术连接，并使医疗保健组织难以实施整合方法。标准化的缺乏不仅使得建立全面且可互通的解决方案变得困难，而且还限制了医嘱遵从性干预的可扩展性和有效性。然而，医疗保健专业人员很难收集和评估各种医嘱遵从性技术的资料，从而更难得出有洞察力的推论并提供客製化的治疗。

慢性病负担增加

随着糖尿病、心臟病和呼吸系统疾病等疾病变得越来越普遍，个人继续按处方使用药物以有效控制疾病至关重要。慢性病治疗复杂且长期，因此确保患者遵守建议的用药时间表对于避免问题和促进整体健康至关重要。此外，对医嘱遵从性解决方案不断增长的需求正在推动支持和追踪药物依从性的产品和服务的创新。

药物医嘱遵从性解决方案的成本

儘管尖端技术和数位平台提供了提高处方合规性的复杂方法，但与这些解决方案相关的初期成本和持续成本可能令人望而却步。医疗保健付款人、医疗保健提供者以及在某些情况下的患者也会受到此成本问题的影响。在资源有限的环境中，实施和维护数位监控系统和智慧设备等医嘱遵从性技术可能会对医疗保健成本造成压力。经济限制可能会阻碍这些治疗方法的广泛采用，从而影响其有效性和对不同患者群体的可及性。

COVID-19 的影响

大流行的影响，包括医疗机构关闭和医疗系统超负荷，凸显了患者按处方服用处方药的重要性。作为管理和预防併发症的一种方法，药物医嘱遵从性变得越来越重要。此外，大流行期间远端医疗的普及为远端监控和药物医嘱遵从性支援创造了机会。

以软体为中心的细分市场预计将在预测期内成为最大的细分市场

以软体为中心的类别预计将占据最大占有率，重点是基于软体的干预措施，例如网路平台、行动应用程式和电子健康记录连接。这些软体解决方案通常包括给药追踪、即时监测和用药提醒等功能。此外，它还促进患者和医疗保健专业人员之间的沟通，并实现客製化的医嘱遵从性计划。透过整合人工智慧、机器学习和资料分析来根据特定患者需求客製化干预措施，以软体为中心的行业正在经历快速创新。

预计癌症产业在预测期内将经历最高的复合年增长率。

由于重点在于提高接受癌症治疗的患者的药物医嘱遵从性，肿瘤学领域预计将实现盈利成长。癌症药物是如此复杂和强大，保持准确的依从性对于最大化治疗效果至关重要。这些解决方案透过提供个体化药物治疗、剂量提醒和培训资源来提高患者的理解和参与。以肿瘤学为重点的医嘱遵从性策略旨在透过确保患者遵循标靶治疗、化疗和免疫治疗方案来减少给药剂量的潜在影响。Masu。

占有率最高的地区：

由于医疗基础设施的进步、对慢性病的认识提高以及数位健康解决方案的使用增加，预计亚太地区将占据最大占有率。为了降低慢性病的发生率，越来越需要考虑人口规模和年龄的有效药物医嘱遵从性措施。此外，亚太市场最近的开拓是越来越多地创建和使用以软体为中心的解决方案，这些解决方案透过利用数位平台和行动应用程式来提高患者的参与度和医嘱遵从性。

复合年增长率最高的地区：

由于医疗保健投资和政府措施的增加，预计亚太地区将实现盈利成长。亚太地区多样化的医疗保健形势和独特的经济状况证明了一种适应性强且具有文化敏感性的方法。因此，创新和客製化对于应对这个充满活力且快速变化的区域药物治疗实施市场的独特机会和挑战至关重要。

免费客製化服务：

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球药物医嘱遵从性市场：依类型

  • 介绍
  • 以软体为中心
  • 以硬体为中心
    • 自动点胶系统
    • 电子托盘
    • 智慧药瓶
  • 其他类型

第六章全球药物医嘱遵从性市场：依药物分类

  • 介绍
  • 肌肉骨骼系统
  • 胃
  • 癌症
  • 糖尿病
  • 中枢神经系统
  • 心血管
  • 风湿病
  • 其他药品

第七章全球药物医嘱遵从性市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第八章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第九章 公司简介

  • Aardex Group
  • AdhereTech Inc.,
  • Caredose
  • CareFusion（Becton Dickenson）
  • DrFirst.com, Inc.
  • ELucid MHealth
  • Fruitech Ltd.
  • Health Beacon
  • HealthEra
  • Johnson And Johnson Services Inc
  • McKesson Corporation
  • MedAdvisor International Pty Ltd
  • PHC Holdings Corporation
  • Propeller Health
  • Proteus Digital Health
Product Code: SMRC24449

According to Stratistics MRC, the Global Medication Adherence Market is accounted for $4,403.1 million in 2023 and is expected to reach $13,615.3 million by 2030 growing at a CAGR of 17.5% during the forecast period. An important component of medical treatment accomplishment is medication adherence, or the extent to which patients adhere to their recommended prescription regimes. A variety of technologies, therapies, and services are available on the market with the aim of enhancing and tracking patient adherence to drug regimes. In order to improve communication between healthcare providers and patients and eventually ensure individuals follow their recommended medication routines, innovations in this sector include wearable technology, smart pill dispensers, mobile health apps, and patient education programs.

According to a CMS.gov December 2022 update, national health expenditure grew 2.7% to USD 4.3 trillion in 2021, or USD 12,914 per person, and accounted for 18.3% of the Gross Domestic Product (GDP) in the United States.

Market Dynamics:

Driver:

Regulatory initiatives

The substantial impact that medication non-adherence has on healthcare outcomes and expenditures is becoming increasingly recognized by governments and regulatory authorities in the healthcare industry globally. In response, a number of laws and guidelines have been put into effect to promote the use of medication adherence programs. Additionally, guidelines encouraging the use of technology-driven adherence tools, payment incentives for healthcare professionals using adherence techniques, and the incorporation of adherence measurements into quality reporting metrics are just a few instances of these initiatives. A supportive regulatory framework promotes the creation and application of cutting-edge adherence services and technologies.

Restraint:

Lack of standardization

The lack of standardized protocols and data formats impedes technology connectivity, making it challenging for healthcare organizations to implement an integrated approach. This lack of standardization restricts the scalability and effectiveness of adherence interventions, in addition to making the creation of comprehensive and interoperable solutions more difficult. However, it may be challenging for healthcare professionals to gather and assess data from various adherence technologies, which makes it more difficult to arrive at insightful inferences and deliver customized therapy.

Opportunity:

Rising chronic disease burden

As diseases like diabetes, heart problems, and respiratory disorders become more common, it is crucial that individuals keep using medications as prescribed in order to effectively manage illness. Because chronic therapies are complex and long-term, it is essential for patients to adhere to their recommended drug schedules in order to avoid issues and enhance their overall health. Moreover, innovation in products and services that support and track medication compliance is being fueled by the increased need for adherence solutions.

Threat:

Cost of adherence solutions

The upfront costs and continuous expenses associated with these solutions can be prohibitively expensive, even though cutting-edge technologies and digital platforms provide sophisticated ways to enhance prescription compliance. Healthcare payers, providers, and, in certain situations, patients are all affected by this cost issue. In contexts with limited resources, the implementation and maintenance of adherence technologies like digital monitoring systems and smart devices could put pressure on healthcare costs. Financial constraints may prevent these treatments from being widely adopted, which would affect their efficacy and accessibility for a range of patient populations.

COVID-19 Impact:

The pandemic's effects, including lockdowns and overloaded healthcare systems, emphasized how important it is for patients to take their prescriptions as prescribed. Medication adherence has become more important as a way to manage and prevent complications, as there is a greater understanding of the way the virus can have serious effects on those with chronic diseases. Additionally, the pandemic's rapid telehealth uptake has created opportunities for remote monitoring and adherence assistance.

The software centric segment is expected to be the largest during the forecast period

With a focus on software-based interventions such as web platforms, mobile applications, and electronic health record connections, the software-centric category is predicted to have the largest share. Patients have the ability to manage their treatment programs with the help of these software solutions, which frequently include features like dosage tracking, real-time monitoring, and drug reminders. Additionally, they also make it easier for patients and healthcare professionals to communicate, enabling customized adherence plans. With the integration of AI, ML, and data analytics to customize interventions to specific patient needs, the software-centric sector is experiencing exponential innovation.

The oncology segment is expected to have the highest CAGR during the forecast period

With an emphasis on enhancing drug adherence for patients undergoing cancer treatment, the oncology segment is predicted to experience profitable growth. Because oncology medicines are so complex and intense, maintaining precise compliance is essential to maximizing therapeutic outcomes. These solutions improve the patient's understanding and participation by offering individualized drug treatments, dose reminders, and training resources. Adherence strategies with an emphasis on oncology are designed to mitigate the possible effects of missed doses, making sure patients execute their targeted therapy, chemotherapy, or immunotherapy regimes.

Region with largest share:

Owing to the region's developing healthcare infrastructure, growing awareness of chronic illnesses, and growing use of digital health solutions, the Asia-Pacific area is anticipated to hold the largest percentage. In order to address the incidence of chronic illnesses, there is an increasing need for medication adherence measures that are effective considering the size and age of the population. Moreover, a recent development in the Asia-Pacific market is the increased creation and use of software-centric solutions that improve patient engagement and adherence by utilizing digital platforms and mobile applications.

Region with highest CAGR:

As a result of growing healthcare investments and government initiatives, the Asia-Pacific area is anticipated to have profitable growth. The Asia Pacific region's varied healthcare landscape and distinct economic circumstances indicate adaptable and culturally sensitive approaches, which is why innovation and customization are essential for tackling the particular opportunities and challenges within the medication adoption market in this vibrant and rapidly changing region.

Key players in the market:

Some of the key players in Medication Adherence market include Aardex Group, AdhereTech Inc., Caredose, CareFusion (Becton Dickenson), DrFirst.com, Inc., ELucid MHealth, Fruitech Ltd., Health Beacon, HealthEra, Johnson And Johnson Services Inc, McKesson Corporation, MedAdvisor International Pty Ltd, PHC Holdings Corporation, Propeller Health and Proteus Digital Health.

Key Developments:

In August 2022, Athenahealth added an automated patient engagement feature to help with medication adherence. The new release of the athenaOne EHR and practice management suite includes DrFirst's RxInform automated patient messaging to help patients follow prescribed treatment plans.

In January 2022, CareDxl expanded its medication adherence services with the acquisition of the Transplant Pharmacy. The Transplant Pharmacy provides individualized transplant pharmacy services for patients at multiple transplant centers throughout the United States.

Types Covered:

  • Software Centric
  • Hardware Centric
  • Other Types

Medications Covered:

  • Musculoskeletal
  • Gastrointestinal
  • Oncology
  • Diabetes
  • Central Nervous System
  • Cardiovascular
  • Rheumatology
  • Other Medications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Emerging Markets
  • 3.7 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medication Adherence Market, By Type

  • 5.1 Introduction
  • 5.2 Software Centric
  • 5.3 Hardware Centric
    • 5.3.1 Automated Dispensing Systems
    • 5.3.2 Electronic Trays
    • 5.3.3 Smart Pill Bottles
  • 5.4 Other Types

6 Global Medication Adherence Market, By Medication

  • 6.1 Introduction
  • 6.2 Musculoskeletal
  • 6.3 Gastrointestinal
  • 6.4 Oncology
  • 6.5 Diabetes
  • 6.6 Central Nervous System
  • 6.7 Cardiovascular
  • 6.8 Rheumatology
  • 6.9 Other Medications

7 Global Medication Adherence Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Aardex Group
  • 9.2 AdhereTech Inc.,
  • 9.3 Caredose
  • 9.4 CareFusion (Becton Dickenson)
  • 9.5 DrFirst.com, Inc.
  • 9.6 ELucid MHealth
  • 9.7 Fruitech Ltd.
  • 9.8 Health Beacon
  • 9.9 HealthEra
  • 9.10 Johnson And Johnson Services Inc
  • 9.11 McKesson Corporation
  • 9.12 MedAdvisor International Pty Ltd
  • 9.13 PHC Holdings Corporation
  • 9.14 Propeller Health
  • 9.15 Proteus Digital Health

List of Tables

  • Table 1 Global Medication Adherence Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
  • Table 4 Global Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
  • Table 5 Global Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
  • Table 6 Global Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
  • Table 7 Global Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
  • Table 8 Global Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 9 Global Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
  • Table 10 Global Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
  • Table 11 Global Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
  • Table 12 Global Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 13 Global Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 14 Global Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
  • Table 15 Global Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 16 Global Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
  • Table 17 Global Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
  • Table 18 North America Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
  • Table 19 North America Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
  • Table 20 North America Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
  • Table 21 North America Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
  • Table 22 North America Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
  • Table 23 North America Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
  • Table 24 North America Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
  • Table 25 North America Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 26 North America Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
  • Table 27 North America Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
  • Table 28 North America Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
  • Table 29 North America Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 30 North America Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 31 North America Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
  • Table 32 North America Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 33 North America Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
  • Table 34 North America Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
  • Table 35 Europe Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
  • Table 36 Europe Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
  • Table 37 Europe Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
  • Table 38 Europe Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
  • Table 39 Europe Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
  • Table 40 Europe Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
  • Table 41 Europe Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
  • Table 42 Europe Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 43 Europe Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
  • Table 44 Europe Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
  • Table 45 Europe Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
  • Table 46 Europe Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 47 Europe Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 48 Europe Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
  • Table 49 Europe Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 50 Europe Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
  • Table 51 Europe Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
  • Table 52 Asia Pacific Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Asia Pacific Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
  • Table 54 Asia Pacific Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
  • Table 55 Asia Pacific Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
  • Table 56 Asia Pacific Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
  • Table 57 Asia Pacific Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
  • Table 58 Asia Pacific Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
  • Table 59 Asia Pacific Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 60 Asia Pacific Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
  • Table 61 Asia Pacific Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
  • Table 62 Asia Pacific Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
  • Table 63 Asia Pacific Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 64 Asia Pacific Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 65 Asia Pacific Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
  • Table 66 Asia Pacific Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 67 Asia Pacific Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
  • Table 68 Asia Pacific Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
  • Table 69 South America Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
  • Table 70 South America Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
  • Table 71 South America Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
  • Table 72 South America Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
  • Table 73 South America Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
  • Table 74 South America Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
  • Table 75 South America Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
  • Table 76 South America Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 77 South America Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
  • Table 78 South America Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
  • Table 79 South America Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
  • Table 80 South America Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 81 South America Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 82 South America Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
  • Table 83 South America Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 84 South America Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
  • Table 85 South America Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
  • Table 86 Middle East & Africa Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
  • Table 87 Middle East & Africa Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
  • Table 88 Middle East & Africa Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
  • Table 89 Middle East & Africa Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
  • Table 90 Middle East & Africa Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
  • Table 91 Middle East & Africa Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
  • Table 92 Middle East & Africa Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
  • Table 93 Middle East & Africa Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 94 Middle East & Africa Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
  • Table 95 Middle East & Africa Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
  • Table 96 Middle East & Africa Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
  • Table 97 Middle East & Africa Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 98 Middle East & Africa Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 99 Middle East & Africa Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
  • Table 100 Middle East & Africa Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 101 Middle East & Africa Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
  • Table 102 Middle East & Africa Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)